Method of Determining or Influencing Chondrogenic Potential of Mesenchymal Stromal Cells

Sat, 18 Apr 2026 01:22:55 +0000
Intellectual Property

USPTO granted Patent US12600952B2 to AO TECHNOLOGY AG on April 14, 2026. The patent covers methods of increasing chondrogenic potential of mesenchymal stromal cells (MSCs) by manipulating TGFβR1, TGFβR2, and ACVRL1 expression levels. The patent contains 23 claims and has 5 CPC classifications spanning cell therapy and peptide technologies.